The National Blood Authority (NBA) periodically undertakes public consultations. The NBA welcomes comments from individuals or groups on topics in the required formats and timeframes.
Imported Plasma and Recombinant Product – Supply Contracts
Submissions Close 10.00am Wednesday 22 July 2015
Under the national blood arrangements administered by the National Blood Authority (NBA), Australia imports a range of plasma derived and recombinant products, to supplement domestic supply and obtain products that are not manufactured in Australia.
Contracts for a number of imported plasma and recombinant products expire on 30 June 2016. The NBA is conducting a Request for Information and Stakeholder Consultation to decide whether to go to tender, negotiate outside the tendering arrangement or to undertake a combination of these actions.
The NBA is interested in seeking feedback from all stakeholders, including clinicians, nurses scientists and suppliers to achieve the best possible outcome from the tender process.
- Supply of Imported Plasma & Recombinant Products: Stakeholder Consultation (pdf) (2.72 MB)
- Supply of Imported Plasma & Recombinant Products: Stakeholder Consultation (docx) (363.15 KB)
- Supply of Imported Plasma & Recombinant Products: Request For Information (pdf) (3.81 MB)
- Supply of Imported Plasma & Recombinant Products: Request For Information (pdf) (297.7 KB)
To view outcomes from previous consultations visit Closed Public Consultations.